SG3 Management, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 57 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$21,000
-87.7%
14,200
-77.9%
0.00%
-100.0%
Q3 2021$171,000
-80.5%
64,200
-71.0%
0.01%
-83.9%
Q2 2021$878,000
+1191.2%
221,743
+1461.6%
0.03%
+1450.0%
Q1 2021$68,000
-32.0%
14,2000.0%0.00%0.0%
Q4 2020$100,00014,2000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders